Home >
Dr. Bappaditya Chatterjee

Dr. Bappaditya Chatterjee

Assistant Professor

Qualification : PhD in Pharmacy

Specialization : Pharmaceutics

E mail : bappaditya.chatterjee@nmims.edu

Phone : 022 42332020 

Experience : Total in years 12

(Industry – 2 years, Academics-10 years)

Dr Bappaditya has worked in Fresenius-Kabi Oncology Ltd, a Germany based leading anticancer drug manufacturer for almost 2 yrs. In that company, he acquired experience of working under US FDA approved regulatory system. After that Dr Bappaditya joined Pharmaceutical Technology Department, International Islamic University Malaysia (IIUM), Malaysia as an Assistant Professor. He worked there more than 6 yrs. until July’2019.

Interest areas: Amorphous formulation based approaches for bioavailability enhancement, Development of lipid based nano-formulation such as nanoemulsion, SNEDDS, Development of transdermal lipid based formulations 


  • Publications – Total number 69 (International- 60 , National- 9 )
  • Books- 2
  • Book Chapters- Total number 6
  • Patents- Total number
  • Presentations- Total number (International- 16, National- 2)
  • Government funded projects – (Government of Malaysia) – 5 (3 as Principal Investigator, 2 as Co-investigator) Completed
  1. Project title: Nano-transferosomes as a Novel Elastic Transdermal Carrier to Address Poor Bioavailability Issue of Raloxifene Hydrochloride Role: Principal researcher Funding Scheme: Fundamental Research Grant Scheme (FRGS) by Ministry of Higher Education, Malaysia Fund received: MYR 1,32000 (INR 2508000)
  2. Project title: Enhancement of drug loading with dry surface coated active ingredient in direct compression: an approach to prepare tablet in a time saving cost effective manner Role: Principal researcher Scheme: Research Acculturation Collaborative Effort (RACE) Ministry of Higher Education, Malaysia Fund received: MYR 44000 (INR 8,36000)
  3. Project title: Evaluation of safety profile of a Fixed dose combination of Antidiabetic and Antihypertensive drug by toxicity profiling and pharmacokinetic interaction study Role: Co-researcher Scheme: Fundamental Research Grant Scheme (FRGS) Ministry of Higher Education, Malaysia Fund received: MYR 82000 (INR 15,58000)
  4. Project title: Incorporation of stingless bee honey into hydrogel as a potential wound healing promoter Role: Co-researcher Scheme: Fundamental Research Grant Scheme (FRGS) Ministry of Higher Education, Malaysia Fund received: MYR 75000 Status: Complete (July 2018)
  5. Project title: Naso-mucosal absorption of neuronal drug by sol-to-gel delivery system to target brain: approach to dose reduction Role: Principal researcher Scheme: Fundamental Research Grant Scheme (FRGS) Ministry of Higher Education, Malaysia Fund received: MYR 74,800 (INR 14,21,200) Ongoing since Aug’ 2017 (duration: 2.5 yrs.) Industry projects

Ongoing: (Industry) Comparative evaluations between some novel and conventional excipient, A multinational excipient manufacturing company, 4.40 L

Product commercialized- 1 (in Malaysia)

Conferences/Workshops/Seminars attended- 25

Academic activities

He/She has guided 18 no. of M.Pharm. students for their research projects.

He/she has guided 2 no. of PhDs successfully


  • Best performer award in the Faculty Development Program of AICTE held in Oct’2020, organized by MRSPTU, Bhatinda.
    • Best oral presenter award at the International Conference on Pharmaceutical Research & Practice (ICPRP, 2018), held at Yogyakarta, Indonesia in October’2018.
    • Promising researcher award- 2018 in Medical and Allied Health Science by International Islamic University Malaysia (IIUM)
    • Award for potential contribution to "IIUM MyRA (Malaysia Research Assessment) 2015 Five Star rating” by International Islamic University Malaysia (IIUM)
    • Awarded the Senior Research Fellowship (SRF) by the Govt. of West Bengal, India for carrying out Ph.D. work
    • Qualified Graduate Aptitude Test in Engineering (GATE ’2005) with 98.86 percentile (All India rank:132)

Professional Memberships

  • American Chemical Society (ACS)-India
    • Indian Pharmaceutical Association (Life member)
    • Controlled Release Society (India chapter)
    • Society for Pharmaceutical Dissolution Science
    • Chemical, Biological and Environmental Engineering Society (CBEES)

Recent Publications

  1. Mohananaidu, K., Chatterjee, B*., Mohamed, F., Mahmood, S., & Hamed Almurisi, S. (2023). Thermoreversible Carbamazepine In Situ Gel for Intranasal Delivery: Development and In Vitro, Ex Vivo Evaluation. AAPS PharmSciTech, 23(8), 1-14. IF 4.026
  2. Oo, M. K., Alallam, B., Doolaanea, A. A., Khatib, A., Mohamed, F., & Chatterjee, B*. (2022). Exploring the Effect of Glycerol and Hydrochloric Acid on Mesoporous Silica Synthesis: Application in Insulin Loading. ACS omega. 7, 31, 27126–27134, IF 4.132
  3. Palan, F., & Chatterjee, B*. (2022). Dendrimers in the context of targeting central nervous system disorders. Journal of Drug Delivery Science and Technology, 103474. https://doi.org/10.1016/j.jddst.2022.103474, IF 5.062
  4. Mawazi, S. M., Ab Hadi, H…..& Chatterjee, B. (2021). The impact of carbamazepine crystallinity on carbamazepine-loaded microparticle formulations. International Journal of Pharmaceutics,120638. https://doi.org/10.1016/j.ijpharm.2021.120638, IF 5.875
  5. Al-Japairai, K. A., Alkhalidi, H. M., Mahmood, S., Almurisi, S. H., Doolaanea, A. A., Al-Sindi, T. A., & Chatterjee, B*. (2020). Lyophilized Amorphous Dispersion of Telmisartan in a Combined Carrier–Alkalizer System: Formulation Development and In Vivo Study. ACS Omega. (https://doi.org/10.1021/acsomega.0c04588). IF: 2.87

Google scholar: https://scholar.google.com/citations?user=TWFcxTkAAAAJ&hl=en

ORCID: https://orcid.org/0000-0003-1816-6028

SCOPUS: https://www.scopus.com/authid/detail.uri?authorId=55106864100

© Copyright 2023. Shri Vile Parle Kelavani Mandal (SVKM) All Rights Reserved.   Disclaimer  |  Privacy Policy